Computer-Based Drug-Utilization Review — Risk, Benefit, or Boondoggle?
View/ Open
Published Version
https://doi.org/10.1056/NEJM199506153322411Metadata
Show full item recordCitation
Soumerai, Stephen B., and Helene L. Lipton. 1995. “Computer-Based Drug-Utilization Review — Risk, Benefit, or Boondoggle?” New England Journal of Medicine 332 (24) (June 15): 1641–1645. doi:10.1056/nejm199506153322411.Abstract
On October 28, 1990, with little debate, Congress passed the Omnibus Budget Reconciliation Act, requiring the states to provide claims-based drug-utilization review to approximately 34 million Medicaid enrollees. The provisions of the program were borrowed from the ill-fated Medicare Catastrophic Coverage Act of 1988, repealed in 1990; the stated goals were to reduce potentially inappropriate prescribing and dispensing of medications, enhance the counseling of patients, and reduce growth in expenditures for drugs. Drug-utilization review is a structured, ongoing program that interprets patterns of drug use in relation to predetermined criteria and attempts to prevent or minimize inappropriate prescribing.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:32692607
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)